Data‐Driven Computer Simulation of Human Cancer Cell
- 1 May 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1020 (1) , 132-153
- https://doi.org/10.1196/annals.1310.014
Abstract
Using the Diagrammatic Cell Language™, Gene Network Sciences (GNS) has created a network model of interconnected signal transduction pathways and gene expression networks that control human cell proliferation and apoptosis. It includes receptor activation and mitogenic signaling, initiation of cell cycle, and passage of checkpoints and apoptosis. Time‐course experiments measuring mRNA abundance and protein activity are conducted on Caco‐2 and HCT 116 colon cell lines. These data were used to constrain unknown regulatory interactions and kinetic parameters via sensitivity analysis and parameter optimization methods contained in the DigitalCell™ computer simulation platform. FACS, RNA knockdown, cell growth, and apoptosis data are also used to constrain the model and to identify unknown pathways, and cross talk between known pathways will also be discussed. Using the cell simulation, GNS tested the efficacy of various drug targets and performed validation experiments to test computer simulation predictions. The simulation is a powerful tool that can in principle incorporate patient‐specific data on the DNA, RNA, and protein levels for assessing efficacy of therapeutics in specific patient populations and can greatly impact success of a given therapeutic strategy.Keywords
This publication has 14 references indexed in Scilit:
- Development of Human Protein Reference Database as an Initial Platform for Approaching Systems Biology in HumansGenome Research, 2003
- The genetics and genomics of cancerNature Genetics, 2003
- Molecular classification of familial non- BRCA1/BRCA2 breast cancerProceedings of the National Academy of Sciences, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genesBritish Journal of Cancer, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based studyGenetic Epidemiology, 2001
- Gene-Expression Profiles in Hereditary Breast CancerNew England Journal of Medicine, 2001